Erratum: The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4 (Biochemistry (2011) 50 (10804) DOI: 10.1021/bi200924t);The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4

Biochemistry

Volumn 50, Issue 50, 2011, Pages 10804-10818

  Roberts, Arthur G ^a   Yang, Jing ^c   Halpert, James R ^b   Nelson, Sidney D ^c   Thummel, Kenneth T ^c   Atkins, William M ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETICS; CRYSTAL STRUCTURE; LIGANDS; MOLECULAR MODELING; NUCLEAR MAGNETIC RESONANCE; PORPHYRINS; SIMULATED ANNEALING;

ANTIEPILEPTIC DRUGS; DIRECT INTERACTIONS; HETEROTROPIC COOPERATIVITY; HOMOTROPIC COOPERATIVITY; NUCLEAR MAGNETIC RESONANCE (NMR); STACKED CONFIGURATION; STEADY-STATE KINETICS; X RAY CRYSTAL STRUCTURES;

MOLECULES;

4 HYDROXYMIDAZOLAM; ALPHA HYDROXYMIDAZOLAM; CARBAMAZEPINE; CYTOCHROME P450 3A4; DRUG METABOLITE; MIDAZOLAM MALEATE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG METABOLISM; DRUG STRUCTURE; ENZYME ACTIVE SITE; HETEROTROPHY; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 83455163134     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi300045b     Document Type: Erratum

References (90)

1. Guengerich, F. P. (1999) Cytochrome P-450 3A4: Regulation and role in drug metabolism Annu. Rev. Pharmacol. Toxicol. 39, 1-17 (Pubitemid 29222549)
2. Ortiz de Montellano, P. R. (2004) Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd ed., Plenum Publishing, New York.
3. Guengerich, F. P. (1995) Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., Ed.) 2nd ed., Plenum, New York.
4. Atkins, W. M. (2004) Implications of the allosteric kinetics of cytochrome P450s Drug Discovery Today 9, 478-484 (Pubitemid 38626084)
5. Yano, J. K., Wester, M. R., Schoch, G. A., Griffin, K. J., Stout, C. D., and Johnson, E. F. (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05 Å resolution J. Biol. Chem. 279, 38091-38094 (Pubitemid 39295952)
6. Williams, P. A., Cosme, J., Vinkovic, D. M., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., and Jhoti, H. (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone Science 305, 683-686 (Pubitemid 39006760)
7. Sevrioukova, I. F. and Poulos, T. L. (2010) Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir Proc. Natl. Acad. Sci. U.S.A. 107, 18422-18427
8. Ekroos, M. and Sjogren, T. (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4 Proc. Natl. Acad. Sci. U.S.A. 103, 13682-13687 (Pubitemid 44413967)
9. Egnell, A. C., Houston, J. B., and Boyer, C. S. (2005) Predictive models of CYP3A4 heteroactivation: In vitro-in vivo scaling and pharmacophore modeling J. Pharmacol. Exp. Ther. 312, 926-937 (Pubitemid 40293750)
10. Hutzler, J. M., Frye, R. F., Korzekwa, K. R., Branch, R. A., Huang, S. M., and Tracy, T. S. (2001) Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone Eur. J. Pharm. Sci. 14, 47-52 (Pubitemid 32655414)
11. Lasker, J. M., Huang, M. T., and Conney, A. H. (1984) In vitro and in vivo activation of oxidative drug metabolism by flavonoids J. Pharmacol. Exp. Ther. 229, 162-170 (Pubitemid 14082926)
12. Tang, W., Stearns, R. A., Kwei, G. Y., Iliff, S. A., Miller, R. R., Egan, M. A., Yu, N. X., Dean, D. C., Kumar, S., Shou, M., Lin, J. H., and Baillie, T. A. (1999) Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism J. Pharmacol. Exp. Ther. 291, 1068-1074
13. Roberts, A. G., Campbell, A. P., and Atkins, W. M. (2005) The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: Ligand binding and spin state equilibria Biochemistry 44, 1353-1366 (Pubitemid 40209015)
14. Isin, E. M. and Guengerich, F. P. (2006) Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4 J. Biol. Chem. 281, 9127-9136 (Pubitemid 43864626)
15. eryF exhibiting homotropic cooperativity Proc. Natl. Acad. Sci. U.S.A. 97, 3050-3055 (Pubitemid 30183253)
16. Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., and Tracy, T. S. (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites Biochemistry 37, 4137-4147 (Pubitemid 28166435)
17. Ueng, Y. F., Kuwabara, T., Chun, Y. J., and Guengerich, F. P. (1997) Cooperativity in oxidations catalyzed by cytochrome P450 3A4 Biochemistry 36, 370-381 (Pubitemid 27043473)
18. Roberts, A. G. and Atkins, W. M. (2007) Energetics of heterotropic cooperativity between α-naphthoflavone and testosterone binding to CYP3A4 Arch. Biochem. Biophys. 463, 89-101 (Pubitemid 46879710)
19. Koley, A. P., Buters, J. T., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1995) CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers J. Biol. Chem. 270, 5014-5018
20. Koley, A. P., Buters, J. T., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1997) Differential mechanisms of cytochrome P450 inhibition and activation by α-naphthoflavone J. Biol. Chem. 272, 3149-3152 (Pubitemid 27066801)
21. Maenpaa, J., Hall, S. D., Ring, B. J., Strom, S. C., and Wrighton, S. A. (1998) Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: The effect of assay conditions and regioselective stimulation by α-naphthoflavone, terfenadine and testosterone Pharmacogenetics 8, 137-155 (Pubitemid 28227322)
22. Kang, P., Liao, M., Wester, M. R., Leeder, J. S., Pearce, R. E., and Correia, M. A. (2008) CYP3A4-mediated carbamazepine (CBZ) metabolism: Formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile Drug Metab. Dispos. 36, 490-499 (Pubitemid 351409335)
23. Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., and Wrighton, S. A. (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7 Drug Metab. Dispos. 30, 883-891 (Pubitemid 34815417)
24. Maekawa, K., Yoshimura, T., Saito, Y., Fujimura, Y., Aohara, F., Emoto, C., Iwasaki, K., Hanioka, N., Narimatsu, S., Niwa, T., and Sawada, J. (2009) Functional characterization of CYP3A4.16: Catalytic activities toward midazolam and carbamazepine Xenobiotica 39, 140-147
25. 1 paramagnetic relaxation study Biochemistry 44, 14143-14151 (Pubitemid 41533039)
26. Kerr, B. M., Thummel, K. E., Wurden, C. J., Klein, S. M., Kroetz, D. L., Gonzalez, F. J., and Levy, R. H. (1994) Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation Biochem. Pharmacol. 47, 1969-1979
27. Wolkenstein, P., Tan, C., Lecoeur, S., Wechsler, J., Garcia-Martin, N., Charue, D., Bagot, M., and Beaune, P. (1998) Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin Chem.-Biol. Interact. 113, 39-50 (Pubitemid 28279790)
28. Nakamura, H., Torimoto, N., Ishii, I., Ariyoshi, N., Nakasa, H., Ohmori, S., and Kitada, M. (2003) CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids Drug Metab. Dispos. 31, 432-438 (Pubitemid 36378520)
29. Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., and Thummel, K. E. (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism J. Pharmacol. Exp. Ther. 283, 1552-1562 (Pubitemid 28016533)
30. Segel, I. H. (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley & Sons, Inc., New York.
31. Copeland, R. A. (2000) Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, 2nd ed., Wiley-VCH, Weinheim, Germany.
32. Gillam, E. M., Baba, T., Kim, B. R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme Arch. Biochem. Biophys. 305, 123-131 (Pubitemid 23242002)
33. Froger, A. and Hall, J. E. (2007) Transformation of plasmid DNA into E. coli using the heat shock method J. Visual Exp., 253
34. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties J. Biol. Chem. 239, 2379-2385
35. Meunier, D. M. (1997) Molecular weight determinations. In Handbook of Instrumental Techniques for Analytical Chemistry (Settle, F. A., Ed.), pp xxi, Prentice Hall PTR, Upper Saddle River, NJ.
36. Jefcoate, C. R. (1978) Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy Methods Enzymol. 52, 258-279
37. Hildebrandt, A., Remmer, H., and Estabrook, R. W. (1968) Cytochrome P-450 of liver microsomes: One pigment or many Biochem. Biophys. Res. Commun. 30, 607-612
38. Fernando, H., Halpert, J. R., and Davydov, D. R. (2006) Resolution of multiple substrate binding sites in cytochrome P450 3A4: The stoichiometry of the enzyme-substrate complexes probed by FRET and Jobs titration Biochemistry 45, 4199-4209
39. Morrison, J. F. (1969) Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors Biochim. Biophys. Acta 185, 269-286
40. Mendes, P. and Kell, D. (1998) Non-linear optimization of biochemical pathways: Applications to metabolic engineering and parameter estimation Bioinformatics 14, 869-883 (Pubitemid 29041543)
41. Davydov, D. R., Deprez, E., Hoa, G. H., Knyushko, T. V., Kuznetsova, G. P., Koen, Y. M., and Archakov, A. I. (1995) High-pressure-induced transitions in microsomal cytochrome P450 2B4 in solution: Evidence for conformational inhomogeneity in the oligomers Arch. Biochem. Biophys. 320, 330-344
42. Renaud, J. P., Davydov, D. R., Heirwegh, K. P., Mansuy, D., and Hui Bon Hoa, G. H. (1996) Thermodynamic studies of substrate binding and spin transitions in human cytochrome P-450 3A4 expressed in yeast microsomes Biochem. J. 319 (Part 3) 675-681 (Pubitemid 26386176)
43. Roberts, A. G., Sjogren, S. E., Fomina, N., Vu, K. T., Almutairi, A., and Halpert, J. R. (2011) NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation Biochemistry 50, 2123-2134
44. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions J. Biomol. NMR 2, 661-665
45. Prost, E., Sizun, P., Piotto, M., and Nuzillard, J. M. (2002) A simple scheme for the design of solvent-suppression pulses J. Magn. Reson. 159, 76-81
46. Bruce, S. D., Higinbotham, J., Marshall, I., and Beswick, P. H. (2000) An analytical derivation of a popular approximation of the Voigt function for quantification of NMR spectra J. Magn. Reson. 142, 57-63
47. Marshall, I., Bruce, S. D., Higinbotham, J., MacLullich, A., Wardlaw, J. M., Ferguson, K. J., and Seckl, J. (2000) Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios Magn. Reson. Med. 44, 646-649
48. 1H spectra Magn. Reson. Med. 37, 651-657 (Pubitemid 27187803)
49. Massiot, D., Fayon, F., Capron, M., King, I., Calvé, S. L., Alonso, B., Durand, J.-O., Bujoli, B., Gan, Z., and Hoatson, G. (2002) Modelling one- and two-dimensional solid-state NMR spectra Magn. Reson. Chem. 40, 70-76 (Pubitemid 37296946)
50. 1H NMR spectra Chemom. Intell. Lab. Syst. 20, 231-238
51. 31P NMR spectra via principal component analysis: Potential and limitations NMR Biomed. 9, 93-104 (Pubitemid 26368120)
52. Stoyanova, R. and Brown, T. R. (2001) NMR spectral quantitation by principal component analysis NMR Biomed. 14, 271-277 (Pubitemid 32611439)
53. Kielkopf, J. F. (1973) New approximation to the Voigt function with applications to spectral-line profile analysis J. Opt. Soc. Am. 63, 987-995
54. Lupu, M. and Todor, D. (1995) A singular value decomposition based algorithm for multicomponent exponential fitting of NMR relaxation signals Chemom. Intell. Lab. Syst. 29, 11-17
55. Xu, Q., Sachs, J. R., Wang, T. C., and Schaefer, W. H. (2006) Quantification and identification of components in solution mixtures from 1D proton NMR spectra using singular value decomposition Anal. Chem. 78, 7175-7185 (Pubitemid 44607560)
56. Alipanahi, B., Gao, X., Karakoc, E., Donaldson, L., and Li, M. (2009) PICKY: A novel SVD-based NMR spectra peak picking method Bioinformatics 25, i268-i275
57. Trbovic, N., Smirnov, S., Zhang, F., and Bruschweiler, R. (2004) Covariance NMR spectroscopy by singular value decomposition J. Magn. Reson. 171, 277-283
58. Grahn, H., Delaglio, F., Delsuc, M. A., and Levy, G. C. (1988) Multivariate data analysis for pattern recognition in two-dimensional NMR J. Magn. Reson. 77, 294-307
59. Stoica, P., Selen, Y., Sandgren, N., and Van Huffel, S. (2004) Using prior knowledge in SVD-based parameter estimation for magnetic resonance spectroscopy: The ATP example IEEE Trans. Biomed. Eng. 51, 1568-1578 (Pubitemid 39100230)
60. Chen, H., Van Huffel, S., van Ormondt, D., and de Beer, R. (1996) Parameter estimation with prior knowledge of known signal poles for the quantification of NMR spectroscopy data in the time domain J. Magn. Reson., Ser. A 119, 225-234 (Pubitemid 126751718)
61. Viereck, N., Nørgaard, L., Bro, R., and Engelsen, S. B. (2006) Chemometric Analysis of NMR Data. In Modern Magnetic Resonance (Webb, G. A., Ed.) pp 1833-1843, Springer, Dordrecht, The Netherlands.
62. Kowalewski, J. and Mäler, L. (2006) Nuclear spin relaxation in liquids: Theory, experiments, and applications, Taylor & Francis, New York.
63. Cameron, M. D., Wen, B., Roberts, A. G., Atkins, W. M., Campbell, A. P., and Nelson, S. D. (2007) Cooperative binding of acetaminophen and caffeine within the P450 3A4 active site Chem. Res. Toxicol. 20, 1434-1441 (Pubitemid 350057212)
64. Villafranca, J. J. (1989) Paramagnetic probes of macromolecules Methods Enzymol. 177, 403-413 (Pubitemid 20041588)
65. Solomon, I. (1955) Relaxation processes in a system of two spins Phys. Rev. 99, 559-565
66. Modi, S., Primrose, W. U., Boyle, J. M., Gibson, C. F., Lian, L. Y., and Roberts, G. C. (1995) NMR studies of substrate binding to cytochrome P450 BM3: Comparisons to cytochrome P450cam Biochemistry 34, 8982-8988
67. Dwek, R. A. (1973) Nuclear Magnetic Resonance (N.M.R.) in Biochemistry: Applications to Enzyme Systems, Oxford University Press, Oxford, U.K.
68. Tsalkova, T. N., Davydova, N. Y., Halpert, J. R., and Davydov, D. R. (2007) Mechanism of interactions of α-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe Biochemistry 46, 106-119 (Pubitemid 46075020)
69. Davydov, D. R., Fernando, H., and Halpert, J. R. (2006) Variable path length and counter-flow continuous variation methods for the study of the formation of high-affinity complexes by absorbance spectroscopy. An application to the studies of substrate binding in cytochrome P450 Biophys. Chem. 123, 95-101 (Pubitemid 44279169)
70. Clore, G. M. and Iwahara, J. (2009) Theory, practice, and applications of paramagnetic relaxation enhancement for the characterization of transient low-population states of biological macromolecules and their complexes Chem. Rev. 109, 4108-4139
71. 1H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule J. Am. Chem. Soc. 126, 5879-5896 (Pubitemid 38621427)
72. Gay, S. C., Roberts, A. G., Maekawa, K., Talakad, J. C., Hong, W. X., Zhang, Q., Stout, C. D., and Halpert, J. R. (2010) Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel Biochemistry 49, 8709-8720
73. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 19, 1639-1662 (Pubitemid 128590223)
74. Eswar, N., Eramian, D., Webb, B., Shen, M. Y., and Sali, A. (2008) Protein structure modeling with MODELLER Methods Mol. Biol. 426, 145-159
75. Halgren, T. A. (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 J. Comput. Chem. 17, 490-519 (Pubitemid 126567067)
76. Helms, V. and Wade, R. C. (1995) Thermodynamics of water mediating protein-ligand interactions in cytochrome P450cam: A molecular dynamics study Biophys. J. 69, 810-824
77. Brunger, A. T., Adams, P. D., and Rice, L. M. (1997) New applications of simulated annealing in X-ray crystallography and solution NMR Structure 5, 325-336 (Pubitemid 27169934)
78. Clore, G. M. and Schwieters, C. D. (2002) Theoretical and computational advances in biomolecular NMR spectroscopy Curr. Opin. Struct. Biol. 12, 146-153 (Pubitemid 34327473)
79. Knight, J. L., Mekler, V., Mukhopadhyay, J., Ebright, R. H., and Levy, R. M. (2005) Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: Developing benchmarks of model quality and reliability Biophys. J. 88, 925-938 (Pubitemid 40975928)
80. Yue, S. Y. (1990) Distance-constrained molecular docking by simulated annealing Protein Eng. 4, 177-184
81. Constantine, K. L. (2001) Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints Biophys. J. 81, 1275-1284 (Pubitemid 32783572)
82. Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., and Berendsen, H. J. (2005) GROMACS: Fast, flexible, and free J. Comput. Chem. 26, 1701-1718 (Pubitemid 43076182)
83. Oostenbrink, C., Soares, T. A., van der Vegt, N. F., and van Gunsteren, W. F. (2005) Validation of the 53A6 GROMOS force field Eur. Biophys. J. 34, 273-284 (Pubitemid 40884072)
84. Gunsteren, W. F. v., Billeter, S. R., Eising, A. A., Hunenberger, P. H., Kruger, P., Mark, A. E., Scott, W. R. P., and Tironi, I. G. (1996) Biomolecular Simulation: The GROMOS96 Manual and User Guide, Verlag der Fachvereine Hochschulverlag AG an der ETH Zurich, Zurich.
85. Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald: An N-log(N) method for Ewald sums in large systems J. Chem. Phys. 98, 10089-10092
86. von Moltke, L. L., Greenblatt, D. J., Schmider, J., Duan, S. X., Wright, C. E., Harmatz, J. S., and Shader, R. I. (1996) Midazolam hydroxylation by human liver microsomes in vitro: Inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents J. Clin. Pharmacol. 36, 783-791 (Pubitemid 26329500)
87. Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F. J., and Meyer, U. A. (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4 Mol. Pharmacol. 36, 89-96 (Pubitemid 19191264)
88. Khan, K. K., He, Y. Q., Domanski, T. L., and Halpert, J. R. (2002) Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation Mol. Pharmacol. 61, 495-506 (Pubitemid 34171915)
89. Cazali, N., Tran, A., Treluyer, J. M., Rey, E., dAthis, P., Vincent, J., and Pons, G. (2003) Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human Br. J. Clin. Pharmacol. 56, 526-536 (Pubitemid 37386507)
90. Fishelovitch, D., Hazan, C., Shaik, S., Wolfson, H. J., and Nussinov, R. (2007) Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4 J. Am. Chem. Soc. 129, 1602-1611